FDA closes investigation into Salmonella outbreak traced to moringa powder
The FDA has concluded its investigation into an outbreak of Salmonella infections linked to Rosabella brand moringa powder capsules distributed by Ambrosia Brands LLC.
As of April 1, 10 patients from eight states have been confirmed in the Salmonella Newport and Salmonella Kentucky outbreak. Three of the patients had to be hospitalized. Outbreak strains are highly resistant to all first-line and alternative antibiotics commonly recommended for the treatment of Salmonella infections.
The illnesses began between September 26, 2025 and January 8, 2026. Of the eight people interviewed, seven reported consuming Rosabella brand moringa powder capsules. There are likely many more sick people associated with this outbreak, because for every confirmed patient in a salmonella outbreak, 29 people go undetected, according to the Centers for Disease Control and Prevention.
As part of the outbreak investigation, the Indiana Department of Health collected samples of unopened products from a sick person’s home. The sample tested positive for Salmonella Newport and according to whole genome sequencing According to the analysis, it is the same strain of Salmonella Newport that caused the illnesses in this outbreak.
In response to the investigation, Ambrosia Brands, LLC recalled certain lots of Rosabella brand moringa powder capsules on February 13, 2026. The recalled product was available for sale nationwide and internationally. The product that tested positive for Salmonella was included in the recall. This product should no longer be on the market, but it has a long shelf life. Retailers and consumers should check for recalled products and discard them if located.
For a list of batches recalled in connection with the epidemic, Click here.
